Moreover, enhancing cathepsin activity associated with neuroprotective outcomes constitutes another potential strategy of reducing PD-associated neurodegeneration, and further research is necessary to fully elucidate their implication in PD pathogenesis. Here, CTSS is linked to Parkinson disease.